117 related articles for article (PubMed ID: 38692174)
61. Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting.
Sakurai Y; Mizumura W; Murata M; Hada T; Yamamoto S; Ito K; Iwasaki K; Katoh T; Goto Y; Takagi A; Kohara M; Suga H; Harashima H
Mol Pharm; 2017 Oct; 14(10):3290-3298. PubMed ID: 28789523
[TBL] [Abstract][Full Text] [Related]
62. Cigarette Smoke Induces Metabolic Reprogramming of the Tumor Stroma in Head and Neck Squamous Cell Carcinoma.
Domingo-Vidal M; Whitaker-Menezes D; Martos-Rus C; Tassone P; Snyder CM; Tuluc M; Philp N; Curry J; Martinez-Outschoorn U
Mol Cancer Res; 2019 Sep; 17(9):1893-1909. PubMed ID: 31239287
[TBL] [Abstract][Full Text] [Related]
63. Targeted inhibition of MCT4 disrupts intracellular pH homeostasis and confers self-regulated apoptosis on hepatocellular carcinoma.
Zhao Y; Li W; Li M; Hu Y; Zhang H; Song G; Yang L; Cai K; Luo Z
Exp Cell Res; 2019 Nov; 384(1):111591. PubMed ID: 31479685
[TBL] [Abstract][Full Text] [Related]
64. MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies.
Baek G; Tse YF; Hu Z; Cox D; Buboltz N; McCue P; Yeo CJ; White MA; DeBerardinis RJ; Knudsen ES; Witkiewicz AK
Cell Rep; 2014 Dec; 9(6):2233-49. PubMed ID: 25497091
[TBL] [Abstract][Full Text] [Related]
65. Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack.
Fang Y; Liu W; Tang Z; Ji X; Zhou Y; Song S; Tian M; Tao C; Huang R; Zhu G; Jiang X; Gao J; Qu W; Wang H; Zhou P; Wu X; Jin L; Sun H; Ding Z; Peng Y; Zhao S; Zhou J; Fan J; Xu W; Shi Y
Hepatology; 2023 Jan; 77(1):109-123. PubMed ID: 35043976
[TBL] [Abstract][Full Text] [Related]
66. Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs.
Li YT; Chua MJ; Kunnath AP; Chowdhury EH
Int J Nanomedicine; 2012; 7():2473-81. PubMed ID: 22701315
[TBL] [Abstract][Full Text] [Related]
67. Interaction of monocarboxylate transporter 4 with beta1-integrin and its role in cell migration.
Gallagher SM; Castorino JJ; Philp NJ
Am J Physiol Cell Physiol; 2009 Mar; 296(3):C414-21. PubMed ID: 19073896
[TBL] [Abstract][Full Text] [Related]
68. Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation.
Hanson DJ; Nakamura S; Amachi R; Hiasa M; Oda A; Tsuji D; Itoh K; Harada T; Horikawa K; Teramachi J; Miki H; Matsumoto T; Abe M
Oncotarget; 2015 Oct; 6(32):33568-86. PubMed ID: 26384349
[TBL] [Abstract][Full Text] [Related]
69. Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.
Polański R; Hodgkinson CL; Fusi A; Nonaka D; Priest L; Kelly P; Trapani F; Bishop PW; White A; Critchlow SE; Smith PD; Blackhall F; Dive C; Morrow CJ
Clin Cancer Res; 2014 Feb; 20(4):926-937. PubMed ID: 24277449
[TBL] [Abstract][Full Text] [Related]
70. Nanometer-scale siRNA carriers incorporating peptidomimetic oligomers: physical characterization and biological activity.
Konca YU; Kirshenbaum K; Zuckermann RN
Int J Nanomedicine; 2014; 9():2271-85. PubMed ID: 24872690
[TBL] [Abstract][Full Text] [Related]
71. Involvement of Histidine Residue His382 in pH Regulation of MCT4 Activity.
Sasaki S; Kobayashi M; Futagi Y; Ogura J; Yamaguchi H; Iseki K
PLoS One; 2014; 10(4):e0122738. PubMed ID: 25919709
[TBL] [Abstract][Full Text] [Related]
72. Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer.
Lisanti MP; Sotgia F; Pestell RG; Howell A; Martinez-Outschoorn UE
Cell Cycle; 2013 Sep; 12(18):2935-6. PubMed ID: 23989616
[No Abstract] [Full Text] [Related]
73. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
[TBL] [Abstract][Full Text] [Related]
74. Breathing New Life into TRAIL for Breast Cancer Therapy: Co-Delivery of pTRAIL and Complementary siRNAs Using Lipopolymers.
Thapa B; Kc R; Bahniuk M; Schmitke J; Hitt M; Lavasanifar A; Kutsch O; Seol DW; Uludag H
Hum Gene Ther; 2019 Dec; 30(12):1531-1546. PubMed ID: 31547718
[TBL] [Abstract][Full Text] [Related]
75. Monocarboxylate transporter 4 deficiency enhances high-intensity interval training-induced metabolic adaptations in skeletal muscle.
Tamura Y; Jee E; Kouzaki K; Kotani T; Nakazato K
J Physiol; 2024 Apr; 602(7):1313-1340. PubMed ID: 38513062
[TBL] [Abstract][Full Text] [Related]
76. Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment.
Zhang M; Jiang H; Wu L; Lu H; Bera H; Zhao X; Guo X; Liu X; Cun D; Yang M
J Control Release; 2022 Dec; 352():422-437. PubMed ID: 36265740
[TBL] [Abstract][Full Text] [Related]
77. A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells.
Mboge MY; Chen Z; Khokhar D; Wolff A; Ai L; Heldermon CD; Bozdag M; Carta F; Supuran CT; Brown KD; McKenna R; Frost CJ; Frost SC
Biochem J; 2019 May; 476(10):1497-1513. PubMed ID: 31072911
[TBL] [Abstract][Full Text] [Related]
78.
Chou CH; Chiang CF; Yang CC; Liu YC; Chang SR; Chang KW; Lin SC
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769160
[TBL] [Abstract][Full Text] [Related]
79. Enhanced Delivery of siRNA to Retinal Ganglion Cells by Intravitreal Lipid Nanoparticles of Positive Charge.
Huang X; Chau Y
Mol Pharm; 2021 Jan; 18(1):377-385. PubMed ID: 33295773
[TBL] [Abstract][Full Text] [Related]
80. TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation.
Jena BC; Das CK; Banerjee I; Bharadwaj D; Majumder R; Das S; Biswas A; Kundu M; Roy PK; Kundu CN; Mandal M
Exp Cell Res; 2022 Aug; 417(1):113195. PubMed ID: 35561786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
